Mohammed Abu Alghayth | Hematology | Innovative Research Award

Published on | Editorial Board by World Top Scientists

Innovative Research Award

Mohammed Abu-Alghayth – University of Bisha, Saudi Arabia

Mohammed Abu-Alghayth
Affiliation University of Bisha
Country Saudi Arabia
Scopus ID 57224164348
Documents 31
Citations 345
h-index 12
Subject area Hematology
Event World Top Scientists Awards
ORCID 0009-0008-0125-4041

Mohammed Abu-Alghayth is a researcher affiliated with the University of Bisha, Saudi Arabia. His ORCID record lists scholarly work spanning computational therapeutic research, biological mechanisms, natural products and human blood-related investigations. These publications provide a documented basis for examining his interdisciplinary research contributions and their relevance to scientific innovation. [1]

Abstract

This article outlines the documented research profile of Mohammed Abu-Alghayth and its relevance to the Innovative Research Award. The available ORCID record lists seven works and identifies publications concerning computational approaches to therapeutic discovery, natural-product investigations, oxidative stress and nitrate metabolism. These topics illustrate research across computational and experimental biomedical science. The profile data supplied for this article report 31 documents, 345 citations and an h-index of 12; these metrics should be interpreted in the context of their source and retrieval date. [1]

Keywords

Innovative Research Award; Mohammed Abu-Alghayth; hematology; computational biology; molecular docking; natural products; oxidative stress; redox biology; therapeutic discovery; biomedical research.

Introduction

Scientific innovation often develops through the integration of computational methods, laboratory investigations and analysis of biological processes. Abu-Alghayth’s listed publications include research on biomolecule repurposing, plant-derived compounds and blood-related responses to dietary nitrate. The range of subjects offers a basis for discussing how different research methods can contribute to biomedical questions, while individual findings must be assessed through their original publications rather than inferred from titles alone. [2] [5]

Research Profile

The supplied profile identifies the University of Bisha as the researcher’s affiliation and Saudi Arabia as the country associated with the profile. The ORCID identifier provides a persistent link to the researcher’s public record, while the Scopus author identifier supports discovery of indexed publications. ORCID lists seven works in the supplied record, including articles published between 2021 and 2025. The supplied document count and citation metrics are retained as user-provided values rather than independently verified live statistics. [1] [2]

Research Contributions

One listed study explores computer-aided investigation of biomolecules from Aerva javanica in relation to DDX3X and acute myeloid leukaemia. Its computational framing connects natural-product research with target-focused therapeutic exploration. Such work can generate hypotheses for further experimental validation, although computational predictions alone do not establish clinical efficacy or a treatment recommendation. [2]

Publications

The ORCID record identifies publications in the International Journal of Molecular Sciences, Microbiology Research, Biology, Journal of Food Biochemistry, Arabian Journal of Chemistry, Nitric Oxide and Redox Biology. The subjects range from computational therapeutic approaches and experimental inflammation models to nitrate metabolism and redox-related processes. The five selected references below link to DOI records for individual papers and provide a starting point for checking bibliographic details. [2] [3] [4] [5]

Research Impact

Research impact may be considered through publication records, citation indicators, methodological contribution and the potential for follow-up investigation. The supplied figures of 345 citations and an h-index of 12 offer quantitative indicators, but they can vary between databases and over time. A balanced assessment should also consider the originality of individual studies, reproducibility, contribution to collaborative work and subsequent use of findings by other researchers. [1]

Award Suitability

The documented range of research topics provides material for consideration under an Innovative Research Award, particularly where originality, methodological contribution and potential research value can be demonstrated. The listed computational and experimental studies suggest several lines of inquiry, but the available profile alone does not establish award eligibility or independently prove novelty. Final recognition should follow the award organiser’s published criteria and a review of the full papers, research contributions and supporting evidence. [1] [2]

Conclusion

Mohammed Abu-Alghayth’s listed scholarly work covers several areas of biomedical and biological research, including computational therapeutic exploration, natural products and blood-related biochemical processes. His persistent researcher identifiers and linked DOI records make the publications accessible for further evaluation. The Innovative Research Award provides a relevant recognition context, provided that the originality and significance of the research are assessed against transparent criteria and the original scholarly evidence.

References

  1. ORCID. (n.d.). Mohammed Abu-Alghayth: ORCID record and works. ORCID.
    https://orcid.org/0009-0008-0125-4041
  2. Asiri, A., Alrehaily, A., Al Ali, A., Abu-Alghayth, M. H., & Tasleem, M. (2025). Repurposing biomolecules from Aerva javanica against DDX3X in LAML: A computer-aided therapeutic approach. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms26125445
  3. Al Ali, A., Abu-Alghayth, M. H., Ghaleb, K. I., & Ibrahim, S. (2024). Cicer arietinum extract suppresses lung sepsis induced by cecal ligation and puncture in rats. Microbiology Research, 15(3), 130.
    https://doi.org/10.3390/microbiolres15030130
  4. Rashwan, A. G., Assar, D. H., Salah, A. S., Liu, X., Al-Hawary, I. I., Abu-Alghayth, M. H., et al. (2024). Dietary chitosan attenuates high-fat diet-induced oxidative stress, apoptosis, and inflammation in Nile tilapia (Oreochromis niloticus) through regulation of Nrf2/Keap1 and Bcl-2/Bax pathways. Biology, 13(7), 486.
    https://doi.org/10.3390/biology13070486
  5. Abu-Alghayth, M., Vanhatalo, A., Wylie, L. J., McDonagh, S. T., Thompson, C., Kadach, S., et al. (2021). S-nitrosothiols, and other products of nitrate metabolism, are increased in multiple human blood compartments following ingestion of beetroot juice. Redox Biology.
    https://doi.org/10.1016/j.redox.2021.101974

Mais Musleh | Hematology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr.  Mais Musleh | Hematology | Best Researcher Award

Clinican,Damascus university of medicine, Syria

Dr. Mais Musleh is a skilled Hematology Doctor with over 5 years of clinical and research experience, specializing in hematologic disease diagnosis and treatment. His expertise spans hematologic malignancies, including leukemia, lymphoma, and multiple myeloma, with a focus on chemotherapy and immunotherapy. He currently practices at Al-Manar Private Hospital, Privet Clinic, and Al-Zahra Private Hospital, where he also consults on complex hematology cases. Dr. Musleh is passionate about improving patient outcomes and is deeply committed to continuous learning and research. He has contributed significantly to academic literature, publishing case reports on rare hematologic conditions. His clinical work is complemented by his academic role at Al-Assad University Hospital, where he trains junior staff. Dr. Musleh is a member of prestigious societies like ASCO and SOHO and actively participates in international medical conferences. Fluent in Arabic and English, he is also advancing his proficiency in German.

Profile

Google Scholar

Strengths for the Award

  1. Extensive Experience in Hematology: Dr. Mais Musleh has over 5 years of dedicated experience in the field of hematology, with a specialized focus on diagnosing and treating hematologic malignancies. His hands-on experience in both clinical settings and as an academic trainer positions him as a proficient and well-rounded expert in hematology.
  2. Research Contributions: Dr. Musleh has demonstrated a solid academic track record, publishing multiple case reports in reputable journals such as Clinical Case Reports. Notable works include case reports on rare and complex hematologic conditions, such as multiple myeloma complications, chronic myeloid leukemia relapses, and myeloid sarcoma. His research highlights his ability to investigate and contribute meaningful insights into less understood aspects of hematologic diseases.
    • Example: His publication on “A rare multiple myeloma complication as a spinal cord metastasis” showcases his in-depth understanding of hematological diseases and his capability to investigate complex cases.
    • Example: The ongoing publication of several rare and unusual hematological case reports (e.g., Multiple Myeloma in Down Syndrome and Concurrent Acute Myeloid Leukemia and Autoimmune Hemolytic Anemia) demonstrates both originality and a focus on clinical challenges.
  3. Strong Educational Background: Dr. Musleh holds an advanced academic background, with a Master’s Degree in Hematology and an MD from Damascus University. His academic qualifications combined with his board certification in Hematology reflect his deep understanding of the subject and commitment to advancing his expertise.
  4. Engagement in Professional Development: Dr. Musleh has continuously pursued professional development, attending and obtaining certifications from international conferences, such as the 8th International Congress on Controversies in Stem Cell Transplantation, the 49th Annual EBMT Meeting, and specialized courses on leukemia. This commitment to learning ensures that he remains at the forefront of new developments in his field.
  5. Clinical Expertise and Patient Care: Beyond his research, Dr. Musleh has worked extensively in clinical settings, providing personalized chemotherapy and immunotherapy. His ability to manage complex hematological cases in hospitals and private clinics, including stem cell transplants and acute leukemia, further solidifies his practical expertise.
  6. International Recognition and Collaborations: As a member of respected professional bodies like the American Society of Clinical Oncology (ASCO) and the Society of Hematologic Oncology (SOHO), Dr. Musleh is involved in the global academic and clinical community. This involvement helps foster valuable collaborations and insights, further boosting his reputation in the field.
  7. Multidisciplinary Approach: Dr. Musleh’s work spans across diagnostics, treatment, and academic training, contributing to his well-rounded profile. His experience in mentoring junior staff members shows his leadership in academic hematology, which is essential for fostering future researchers and clinicians.

Areas for Improvement

  1. Research Dissemination and Visibility: While Dr. Musleh has published notable case reports, increasing his publication volume in high-impact journals could further enhance his academic recognition. Broadening the scope of his research by exploring larger-scale studies or clinical trials could also add depth to his scholarly profile.
  2. Interdisciplinary Collaboration: Dr. Musleh could benefit from greater interdisciplinary collaboration with researchers in related fields, such as oncology, immunology, and molecular biology. Collaborating on large, multi-center studies could help elevate his research and increase the potential impact of his findings.
  3. Engagement in Translational Research: As an experienced clinician, Dr. Musleh could expand his research portfolio to include more translational studies that bridge the gap between laboratory research and patient care. Such work can provide more direct insights into clinical applications and influence treatment protocols on a broader scale.
  4. Mentorship and Leadership in Research: While Dr. Musleh has worked as a trainer, further involvement in leading research teams or supervising postgraduate students and fellows could enhance his leadership in the academic realm. As his career progresses, fostering future researchers will be crucial for extending his legacy in the field.
Education 

Dr. Mais Musleh earned his Doctor of Medicine (M.D.) degree from the Faculty of Medicine, Damascus University in 2016, graduating with a “Good” classification. He then pursued a Master’s Degree in Hematology at the same institution, completing it in 2022 with a “Very Good” classification. This educational journey provided him with a strong foundation in medical sciences and a deep understanding of hematologic diseases, particularly blood cancers. Dr. Musleh’s commitment to lifelong learning is reflected in his participation in continuing medical education (CME) programs, including the Certificate of Update CME-CPD (2021-2023). His academic background has been further enhanced by multiple certifications from international training programs and conferences, ensuring he stays at the forefront of developments in hematology and oncology. This combination of rigorous education and continuous professional development equips Dr. Musleh with the knowledge and skills to excel in both clinical practice and research.

Experience 

Dr. Mais Musleh has extensive clinical experience spanning over 5 years in hematology. He began his career as a Hematology Resident at Al-Assad & Al-Mouwassat University Hospitals (2017-2022), where he diagnosed and treated a range of hematologic disorders such as leukemia and lymphoma. His residency included analyzing blood smears and bone marrow aspirates, enabling accurate diagnosis and treatment. Dr. Musleh is currently serving as a Consultant in Hematology at Al-Zahra Private Hospital (2023-present), providing expert consultation on complex hematology cases. He is also a Hematology Doctor at his private clinic, focusing on personalized care with chemotherapy and immunotherapy for patients with hematologic malignancies. Additionally, he has held an Academic Hematology Doctor position at Al-Assad University Hospital (2022-2023), training junior staff in clinical hematology. Dr. Musleh is actively involved in stem cell transplant care at Al-Manar Private Hospital, further advancing his skills in hematology treatment.

Research Focus 

Dr. Mais Musleh’s research focus is on rare and complex hematologic diseases, particularly hematologic malignancies such as leukemia, lymphoma, and multiple myeloma. He has published several case reports that contribute to the understanding of uncommon presentations and complications of these diseases. Notable research topics include chronic myeloid leukemia (CML) relapse in the central nervous system, multiple myeloma complications, and the rare presentation of myeloid sarcoma. His research is characterized by an in-depth exploration of challenging clinical cases, highlighting the need for personalized care and advanced treatment strategies. As an active reviewer for the Annals of Medicine and Surgery Journal, Dr. Musleh is committed to advancing medical knowledge and improving patient care outcomes in hematology. His research aims to bridge gaps in current clinical practices and offer insights into treatment options that can better address the complexities of hematologic diseases.

Publications

  1. “A Rare Multiple Myeloma Complication as a Spinal Cord Metastasis: A Case Report” 📚
  2. “Concurrent Acute Myeloid Leukemia and Autoimmune Hemolytic Anemia: Management Challenges and Clinical Insights: A Rare Case Report” 📖
  3. “A Rare Presentation and Treatment Challenges for Multiple Myeloma in Down Syndrome: A Case Report and Literature Review” 📑
  4. “Myeloid Sarcoma in Brain and Optic Nerve Presented as a Relapse of Acute Myeloid Leukemia: A Case Report” 🧠
  5. “A Chronic Myeloid Leukemia Present with an Unusual Relapse in the Central Nervous System: A Case Report” 🩸
  6. “A Chronic Myeloid Leukemia Patient Presented With an Unusual Relapse in the Central Nervous System: A Case Report” 📘
  7. “Intracranial Plasmacytoma Presented as a Primary Manifestation of Multiple Myeloma: A Case Report” 📄

Conclusion

Dr. Mais Musleh is a highly qualified and accomplished hematology professional with a strong foundation in both clinical care and academic research. His extensive research contributions, particularly in the area of rare hematologic complications, alongside his practical experience, make him an ideal candidate for the Best Researcher Award. His commitment to continuous learning and professional development further supports his candidacy.To further solidify his standing as a leading researcher, Dr. Musleh could expand his research collaborations, focus on large-scale clinical trials, and engage in interdisciplinary and translational research. With continued dedication, he is likely to make even more significant contributions to the field of hematology and oncology in the years to come.